Sepsis trials. Intersection of investigation, regulation, funding, and practice

Am J Respir Crit Care Med. 1995 Jul;152(1):4-10. doi: 10.1164/ajrccm.152.1.7599855.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Clinical Trials as Topic
  • Cyclooxygenase Inhibitors / therapeutic use
  • Endotoxins / antagonists & inhibitors
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Methylprednisolone / therapeutic use
  • Randomized Controlled Trials as Topic
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Research Design
  • Research Support as Topic
  • Sialoglycoproteins / therapeutic use
  • Systemic Inflammatory Response Syndrome* / immunology
  • Systemic Inflammatory Response Syndrome* / therapy
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Cyclooxygenase Inhibitors
  • Endotoxins
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Receptors, Interleukin-1
  • Sialoglycoproteins
  • Tumor Necrosis Factor-alpha
  • Methylprednisolone